Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Interest Expenses (2023 - 2025)

Kura Oncology (KURA) has disclosed Interest Expenses for 3 consecutive years, with $346000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 14.14% to $346000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 6.61% year-over-year, with the annual reading at $1.5 million for FY2025, 6.61% down from the prior year.
  • Interest Expenses for Q4 2025 was $346000.0 at Kura Oncology, down from $393000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $412000.0 in Q3 2024, with the low at $346000.0 in Q4 2025.
  • Average Interest Expenses over 3 years is $390000.0, with a median of $393500.0 recorded in 2023.
  • The sharpest move saw Interest Expenses grew 9.34% in 2024, then fell 14.14% in 2025.
  • Over 3 years, Interest Expenses stood at $394000.0 in 2023, then rose by 2.28% to $403000.0 in 2024, then dropped by 14.14% to $346000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $346000.0, $393000.0, and $391000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.